CYTK

Cytokinetics Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↓ 0/10
Cytokinetics sales and earnings growth
CYTK Growth
Low
  • Revenue Y/Y↑ 429.36%
  • EPS Y/Y↓ -29.30%
  • FCF Y/Y↓ -34.68%
Cytokinetics gross and profit margin trends
CYTK Profitability
Good
  • Gross margin ↑ 97.60%
  • EPS margin↓ -784.00%
  • ROIC 5Y↓ -33.55%
Cytokinetics net debt vs free cash flow
CYTK Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 2.1
  • Interest coverage↓ -15.2

Cytokinetics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks